Mark LeGolvan

476 total citations
14 papers, 344 citations indexed

About

Mark LeGolvan is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Mark LeGolvan has authored 14 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Mark LeGolvan's work include Genetic factors in colorectal cancer (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Mark LeGolvan is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Mark LeGolvan collaborates with scholars based in United States and Switzerland. Mark LeGolvan's co-authors include Alexander K. Andrianov, Murray B. Resnick, Jianping Chen, Ross Taliano, Alfred Ayala, Markus Zuber, Michael I. D’Angelica, Harold J. Wanebo, Philip B. Paty and Chun‐Shiang Chung and has published in prestigious journals such as Macromolecules, The American Journal of Gastroenterology and Biomacromolecules.

In The Last Decade

Mark LeGolvan

14 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark LeGolvan United States	9	88	81	73	66	52	14	344
Alexandra Rausch Germany	5	74 0.8×	155 1.9×	45 0.6×	156 2.4×	36 0.7×	6	431
Ida Franiak‐Pietryga Poland	11	77 0.9×	192 2.4×	135 1.8×	103 1.6×	24 0.5×	25	424
Melinda Burgess Australia	12	23 0.3×	273 3.4×	102 1.4×	146 2.2×	40 0.8×	27	518
Kazumi Yamaguchi Japan	11	47 0.5×	106 1.3×	81 1.1×	249 3.8×	69 1.3×	40	570
Wencke Adriaens Netherlands	6	30 0.3×	138 1.7×	134 1.8×	159 2.4×	91 1.8×	6	485
Tatsuyuki Hayashi Japan	10	19 0.2×	91 1.1×	155 2.1×	54 0.8×	41 0.8×	16	516
Linda Jensen Denmark	14	90 1.0×	416 5.1×	100 1.4×	82 1.2×	20 0.4×	24	785
Irene Müller Germany	16	29 0.3×	191 2.4×	56 0.8×	128 1.9×	112 2.2×	21	669
Manu Thomas Kalathottukaren Canada	11	47 0.5×	163 2.0×	21 0.3×	31 0.5×	90 1.7×	17	554
Stephanie A. Fraser United States	10	26 0.3×	132 1.6×	38 0.5×	146 2.2×	26 0.5×	16	413

Countries citing papers authored by Mark LeGolvan

Since Specialization

Citations

This map shows the geographic impact of Mark LeGolvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark LeGolvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark LeGolvan more than expected).

Fields of papers citing papers by Mark LeGolvan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark LeGolvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark LeGolvan. The network helps show where Mark LeGolvan may publish in the future.

Co-authorship network of co-authors of Mark LeGolvan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark LeGolvan. A scholar is included among the top collaborators of Mark LeGolvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark LeGolvan. Mark LeGolvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bakow, Brianna R., Christopher P. Elco, Mark LeGolvan, Don S. Dizon, & Thomas Ollila. (2020). Molecular Profiles of Brain and Pulmonary Metastatic Disease in Cancer of Unknown Primary. The Oncologist. 25(7). 555–559. 1 indexed citations

Wang, Yihong, Mark LeGolvan, Kimberle C. Chapin, & Martha B. Mainiero. (2018). Cystic neutrophilic granulomatous mastitis with corynebacterium and staphylococcus mimicking breast carcinoma. Clinical Case Reports. 6(11). 2208–2210. 13 indexed citations

Roussel, Breton, et al.. (2018). Late Presenting Celiac Disease and Atypical T-Cell Lymphoproliferative Disorder. The American Journal of Gastroenterology. 113(Supplement). S1441–S1441. 1 indexed citations

Dalal, Rahul S., Mark LeGolvan, Dariusz Stachurski, & Laura Goldberg. (2014). Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapy.. PubMed. 97(8). 28–31. 4 indexed citations

Taliano, Ross, Mark LeGolvan, & Murray B. Resnick. (2012). Immunohistochemistry of colorectal carcinoma: current practice and evolving applications. Human Pathology. 44(2). 151–163. 18 indexed citations

Wanebo, Harold J., Mark LeGolvan, Philip B. Paty, et al.. (2012). Meeting the biologic challenge of colorectal metastases. Clinical & Experimental Metastasis. 29(7). 821–839. 40 indexed citations

LeGolvan, Mark, Ross Taliano, & Murray B. Resnick. (2012). Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach. Human Pathology. 43(8). 1157–1168. 21 indexed citations

Dobrilovic, Nikola, Arun Kumar Singh, Mark LeGolvan, & Frank W. Sellke. (2011). Massive Cardiac Fibroma. Journal of Cardiac Surgery. 26(2). 159–161. 3 indexed citations

LeGolvan, Mark, et al.. (2011). The Dual Functions of Receptor Interacting Protein 1 in Fas-Induced Hepatocyte Death During Sepsis. Shock. 35(5). 499–505. 25 indexed citations

10.

Alverson, Brian, et al.. (2010). A HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE INFANT WITH PROBABLE CONGENITAL HISTOPLASMOSIS IN A NONENDEMIC AREA. The Pediatric Infectious Disease Journal. 29(11). 1055–1057. 7 indexed citations

11.

LeGolvan, Mark & Murray B. Resnick. (2010). Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. Journal of Surgical Oncology. 102(8). 898–908. 36 indexed citations

12.

Glasser, Lewis, et al.. (2007). Florid histiocytic hemophagocytosis following therapy with long acting G‐CSF (pegfilgrastim). American Journal of Hematology. 82(8). 753–757. 12 indexed citations

13.

Andrianov, Alexander K., et al.. (2004). Synthesis and Biologically Relevant Properties of Polyphosphazene Polyacids. Biomacromolecules. 5(5). 1999–2006. 92 indexed citations

14.

Andrianov, Alexander K., Jianping Chen, & Mark LeGolvan. (2003). Poly(dichlorophosphazene) As a Precursor for Biologically Active Polyphosphazenes: Synthesis, Characterization, and Stabilization. Macromolecules. 37(2). 414–420. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact